Prescription Drug User Fee Act

FDA Grants Priority Review for Bluebird Bio's Sickle Cell Treatment

FDA Grants Priority Review for Bluebird Bio’s Sickle Cell Treatment

SG Tylor

Source – bluebird bio On June 21, 2023, the US Food and Drug Administration (FDA) accepted the Biologics Licence Application ...